Ao. Univ.-Prof. Dr. Werner Streif, Medizinische Universität Innsbruck (MUI), Dept. für Kinder- und Jugendheilkunde, Pädiatrie 1, Anichstrasse 35, A - 6020 Innsbruck, Tel: +43-512-504 23600, Fax: +43-512-504 23484, E-Mail:
Hamostaseologie. 2017 Aug 8;37(3):219-222. doi: 10.5482/HAMO-16-09-0038. Epub 2017 Mar 20.
Due to the lack of evidence-based guidelines, management strategies for neonatal MI should be individualized and administered largely at the discretion of responsible treating teams. Supportive care with a focus on preserving adequate circulation and antithrombotic therapy with a view to restoring vascular patency are the mainstays of treatment. Thrombolytic therapy of neonatal MI includes a chance to completely restore myocardial function. Understanding the resilience of the neonatal heart and mechanism of cardiac cell repair in neonates may spark novel treatment strategies for severe MI in the large number of affected individuals in an aging population.
由于缺乏基于证据的指南，新生儿心肌梗死的管理策略应该个体化，并在很大程度上由负责治疗的团队自行决定。以维持足够循环和恢复血管通畅为目标的支持性治疗和抗血栓治疗是治疗的主要方法。新生儿心肌梗死的溶栓治疗有机会完全恢复心肌功能。了解新生儿心脏的弹性和心肌细胞修复的机制，可能为老龄化人口中大量受影响个体的严重心肌梗死提供新的治疗策略。
